cjc+dac
CJC-1295 with DAC (Drug Affinity Complex) is a modified GHRH analog with an extended half-life of approximately 8 days. The DAC modification allows for less frequent dosing while maintaining elevated growth hormone levels.
Lab Notes — Research Studies
01 Prolonged GH-releasing effects of CJC-1295 with DAC
Research shows the DAC modification extends half-life to approximately 8 days, allowing weekly dosing.
View Study ((PubMed))02 Safety and efficacy of CJC-1295
Clinical trials demonstrate sustained IGF-1 elevation with good tolerability in healthy subjects.
View Study ((PubMed))Formula — Benefits & Dosage
⚗️ Effects
- Trade-offs: Convenience vs. less natural pulsatile GH pattern.
- Some Prefer Non-DAC: More natural GH release pattern without DAC.
- Good for Compliance: Better for those who dislike frequent injections.
💉 Dosage & Administration
- Standard Dose: 1-2mg once or twice weekly.
- Subcutaneous: Administered via subcutaneous injection.
- Consistent Timing: Weekly schedule maintains steady levels.
⚠️ Side Effects
- Similar to CJC-1295: Water retention, numbness, joint pain possible.
- Extended Half-Life: Side effects may persist longer due to extended action.
- Generally Well Tolerated: Most users report minimal issues.
📦 Availability & Sourcing
- Research Chemical: Available from peptide suppliers.
- Verify Purity: Important to source from reputable vendors.
- Often Compared: Choose between DAC and non-DAC based on preferences.
Reaction Log — User Experiences
Users appreciate the convenience of weekly dosing. Some prefer non-DAC version for more pulsatile GH release. Results are similar to CJC-1295 without DAC but require less frequent administration.
Synthesis — Related Compounds
⚠️ IMPORTANT DISCLAIMER
This information is for educational and research purposes only. cjc+dac may not be approved for human use. Always consult a qualified healthcare professional before using any supplements or research compounds. We do not guarantee accuracy or completeness of information presented.